SARS-CoV-2 antibodies started to decline just four months after COVID-19 infection in a paediatric populationSARS-CoV-2 항체는 소아 인구에서 COVID-19 감염 후 4개월 만에 감소하기 시작했습니다Article Published on 2021-11-012022-09-12 Journal: Acta paediatrica (Oslo, Norway : 1992) [Category] MERS, SARS, 진단, [키워드] acute respiratory syndrome age antibody antibody levels Antibody testing Antibody titre Asymptomatic asymptomatic infection blood test center children cohort study coronavirus COVID-19 infection cross-sectional eligible evaluated had no Immunity Infection infection rates initial interquartile range intravenous access Jerusalem male not affect Older Patient patients Population Prevalence required SARS-CoV-2 SARS-CoV-2 antibody School School closures seropositive Seropositivity tested [DOI] 10.1111/apa.16031 PMC 바로가기 [Article Type] Article
Dynamics of IgG-avidity and antibody levels after Covid-19Covid-19 이후의 IgG 결합력 및 항체 수준의 역학Article Published on 2021-11-012022-09-11 Journal: Journal of Clinical Virology [Category] MERS, SARS, 진단, 치료기술, 치료법, [키워드] analysed Anti-nucleocapsid Anti-spike antibody antibody level antibody levels Antigen avidity binding blood sample Blood samples COVID-19 declining detectable Dynamics humoral immune response IgG Immunity increase in Infection levels of antibodies levels of antibody longitudinal cohort study majority maturation median median value median values Patient PCR-confirmed predict Prospective Reinfection risk RT-PCR SARS-CoV-2 severe COVID-19 significant decrease significant increase significantly significantly increased Viral viral infections [DOI] 10.1016/j.jcv.2021.104986 PMC 바로가기 [Article Type] Article
Pre-Existing Humoral Immunological Memory Is Retained in Patients with Multiple Sclerosis Receiving Cladribine TherapyArticle Published on 2021-10-312024-09-02 Journal: Biomedicines [Category] 대상포진, [키워드] antibody levels immune reconstitution immunization infections lymphodepletion titers vaccination [DOI] 10.3390/biomedicines9111584 PMC 바로가기 [Article Type] Article
Anti-spike antibody response to natural SARS-CoV-2 infection in the general population일반 인구에서 자연적인 SARS-CoV-2 감염에 대한 항스파이크 항체 반응Article Published on 2021-10-292022-09-12 Journal: Nature Communications [Category] MERS, SARS, 진단, [키워드] anti-spike antibodies anti-Spike IgG antibody antibody levels Antibody Response Antibody responses average Bayesian booster Community COVID-19 infection Cycle threshold value determinant determinants Epidemiology estimate feature female General population immune response infected with SARS-CoV-2 Infection latent class less linear MOST Older participant PCR tests peak level Planning positive swab Reinfection reported responders risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 PCR test seroconvert seroconverted Severe infection subsequent Symptoms the antibody response trajectory understanding United Kingdom vaccination viral burden viral infection [DOI] 10.1038/s41467-021-26479-2 PMC 바로가기 [Article Type] Article
Rapid, robust, and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals회복기 COVID-19 개인에서 mRNA COVID-19 백신에 대한 신속하고 강력하며 지속 가능한 항체 반응Research Article Published on 2021-10-222022-09-12 Journal: JCI Insight [Category] MERS, SARS, 진단, [키워드] 350 patients Adaptive immunity antibody antibody levels Antibody Response BNT162b2 conditions convalescent COVID-19 COVID-19 patients COVID-19 vaccine diagnosed diagnosed with COVID-19 Efficacy elicit evaluate Follow-up Hospitalized immunology individual investigated Longitudinal studies longitudinal study measure mRNA mRNA vaccine neutralizing antibody quantity Rapid rapid increase reached robust SARS-CoV-2 SARS-CoV-2 antibody second dose significantly SNAb specimen the SARS-CoV-2 These data total antibody Vaccine vaccine dose vaccine efficacy [DOI] 10.1172/jci.insight.151477 PMC 바로가기 [Article Type] Research Article
COVID-19 serological evaluation in a cohort of Vaccinated and Seropositive healthcare workers백신 접종 및 혈청 양성 반응을 보이는 의료 종사자 집단에서 COVID-19 혈청학적 평가Article Published on 2021-10-192022-09-11 Journal: Acta bio-medica : Atenei Parmensis [Category] MERS, SARS, 진단, 치료법, [키워드] Acquired age Anti-nucleocapsid antibodies anti-nucleocapsid antibody antibody antibody levels Antibody Response Antibody responses Antibody titer Antibody titers association booster carried category cellular childbearing age chronic degenerative diseases Cohort Complete Course COVID-19 cut-off value degenerative disease dose evaluate examined females Gender greater health problem healthcare worker Healthcare workers Humoral immunity IgG immune system immunoassay Infection material molecular nucleocapsid Pfizer positive positive swab present promote public health R software reported respiratory SARS-CoV-2 serological serological assessment Sex single dose spike statistically significant stratified subject suggested Swab vaccination Vaccine vaccine dose women [DOI] 10.23750/abm.v92iS6.12261 PMC 바로가기 [Article Type] Article
COVID-19 in multiple-myeloma patients: cellular and humoral immunity against SARS-CoV-2 in a short- and long-term view다발성 골수종 환자의 코로나19: 단기 및 장기 관점에서 SARS-CoV-2에 대한 세포 및 체액 면역Case Reports Published on 2021-10-182022-09-10 Journal: Journal of Molecular Medicine (Berlin, Germany) [Category] MERS, SARS, 진단, 치료기술, [키워드] Affect affecting anti-SARS-CoV-2 antibody antibody levels Antibody titer Antibody titers CD4+ T-cell cell activation cellular Cellular immune response Clinical management Combination Continuous Course COVID-19 Decision-making deficiency detectable diagnosed with COVID-19 Disease progression help humoral Humoral immunity Hypogammaglobulinemia IgA IgG antibodies IgM IgM and IgG immune response Immunity immunodeficiency immunological immunomodulatory drugs Immunosuppression infections information inhibitors Innate immunity Isolation lenalidomide Measures memory monoclonal antibodies monoclonal antibody Multiple Multiple myeloma Myeloma neutralizing antibody titers neutropenia Patient performed positive proteasome receiving recommendation remained robust SARS-CoV-2 supplementary material supportive therapy T cell T cell activation T-cell tested the patient therapy treated Treatment underlying disease virus-neutralizing virus-neutralizing antibody [DOI] 10.1007/s00109-021-02114-x PMC 바로가기 [Article Type] Case Reports
Immunoglobulin G antibody response to the Sputnik V vaccine: previous SARS-CoV-2 seropositive individuals may need just one vaccine dose스푸트니크 V 백신에 대한 면역글로불린 G 항체 반응: 이전에 SARS-CoV-2 혈청 양성 반응을 보인 개인은 단 한 번의 백신 접종이 필요할 수 있습니다.Article Published on 2021-10-012022-09-11 Journal: International Journal of Infectious Diseases [Category] MERS, SARS, 진단, 치료법, [키워드] antibody antibody levels Antibody Response antibody response against Antibody responses booster dose Cohort develop domain dose doses enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay evaluated had no IgG IgG antibodies IgG antibody IgG immune response IgG response Immunoglobulin Immunoglobulin G individual individuals nucleocapsid protein nucleocapsid protein (NP) RBD receiving Receptor-binding domain Receptor-binding domain (RBD) S/P S/P ratio SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 antigens second dose seronegative seropositive seropositive individual seropositive subject seropositive subjects significant increase Spike protein Sputnik V vaccine the receptor-binding domain the spike protein the vaccine triggered vaccination Vaccine vaccine booster dose. vaccine dose Venezuela [DOI] 10.1016/j.ijid.2021.07.070 PMC 바로가기 [Article Type] Article
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection증상 및 무증상 SARS-CoV-2 감염에 대한 보호 상관관계Article Published on 2021-09-292022-09-10 Journal: Nature Medicine [Category] MERS, SARS, 변종, 임상, 진단, [키워드] Alpha analyzed Anti-RBD antibodies Anti-spike antibody antibody levels Antibody Units assays asymptomatic infection asymptomatic infections AZD1222 B.1.1.7 binding binding and neutralizing antibodies binding antibody unit binding antibody units can be used ChAdOx1 ChAdOx1 nCoV-19 correlated COVID-19 vaccine COVID-19 vaccines determine Efficacy elicited estimate extrapolation facilitate immune marker immune markers immune response Infectious diseases International international unit majority marker neutralization neutralization titer neutralization titers Neutralizing antibodies neutralizing antibody normalized not correlated Population Predictive pseudovirus Randomized recipients reduced risk SARS-CoV-2 SARS-COV-2 infection second dose significance level symptomatic and asymptomatic symptomatic infection These data Trial United Kingdom Vaccine vaccine efficacy Vaccines variant of SARS-CoV-2 were measured [DOI] 10.1038/s41591-021-01540-1 PMC 바로가기 [Article Type] Article
Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel코로나19 및 예방접종 후 면역: 의료진 대상 1년 이상 추적조사Original Paper Published on 2021-09-252022-09-12 Journal: Infection [Category] COVID19(2023년), SARS, 진단, [키워드] antibody antibody level antibody levels Antibody-mediated immunity booster vaccination cell count cellular immunity controls Course COVID-19 defined ELISA follow-up study Health care Health care worker healthy healthy control healthy individual IgG IgM Immunity individual induce Infection Level magnitude memory T memory T cell quantified Reinfection Result SARS-CoV-2 SARS-CoV-2-vaccination significantly higher specific IgM study participant Study participants subject suffered supplementary material T cell T cells vaccination were measured [DOI] 10.1007/s15010-021-01703-9 PMC 바로가기 [Article Type] Original Paper